JZJiankang Zhu

Jiankang Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiankang Zhu has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Guangyong Zhang

    Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China

    4 shared publications
  • Linchuan Li

    Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China

    4 shared publications
  • Dandan Song

    Department of Neurology, Shandong Province Third Hospital, Jinan, China

    2 shared publications
  • Mingwei Zhong

    Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, 250000, People’s Republic of China

    2 shared publications
  • Qian Xu

    Department of General Surgery The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Jinan Shandong China

    2 shared publications
  • Qian Xu

    Department of General Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Radiomics-based models for the preoperative prediction of high-risk pathological features in gastric cancer: a systematic review and meta-analysis

    by Shichang Cui, Aokun Zhang, Zhengliang Liu, Linchuan Li, Ruizhao Zong, Wuyang Li, Ziwei Zhang, Wenjie Zhang, Jiankang Zhu

  • Open Access

    Enhancing Quality of Life of Proximal Gastrectomy: A Comprehensive Review of Anastomotic Innovations and Challenges

    by Linchuan Li, Dexu Zhang, Siyi Song, Shuohui Dong, Qian Xu, Guangyong Zhang, Jiankang Zhu

    Background: In recent years, the incidence of early upper gastric cancer has increased, leading to a wider adoption of proximal gastrectomy (PG) as a possible treatment option. PG is preferred over total gastrectomy (TG) due to its superior postoperative nutritional status and improved surgical safety. However, PG is associated with a considerable risk of anastomosis‐related complications, such as gastroesophageal reflux and anastomotic stenosis, which limit its widespread application. Methods: We conducted a narrative review of comparative studies, prospective studies and retrospective study, that described reconstructive techniques after PG. End‐points of interest were incidence of reflux esophagitis, anastomotic stenosis, time of follow‐up, nutritional parameters. Results: Esophago‐gastrostomy, the simplest reconstruction method, was associated with highest reflux rates of 18%–55% and stenosis rates of 1.1%–27.8%. Anti‐reflux modifications such as side‐overlap, double‐flap technique (DFT) and gastric tube lowered reflux rate distinctly, especially DFT, lowered reflux rates to 2%–16.7%. But DFT carried a 4%–26.3% stenosis risk and longer operative time. Jejunal interposition (JI) gave 2.1%–100% reflux rates and 0%–31.8% stenosis, yet required three anastomoses and limited endoscopic surveillance. Double‐tract reconstruction (DTR) achieved the promising anti‐reflux outcome, with preserved duodenal passage. However, it may increase surgery costs and prolong surgical time. Conclusion: Our findings provide a solid foundation for reconstruction methods selection that enhance postoperative quality of life and highlight future directions for improving PG outcomes. DTR and DFT, currently offer the best balance between reflux control and anastomotic stenosis after PG. Prospective clinical research and innovation are expected to further improve these techniques and may discover an optimal universal approach to address long‐term challenges.


  • Targeting drug-tolerant persister cells to overcome resistance in HER2-positive gastric cancer

    by Qian Xu, Linchuan Li, Siyi Song, Huanxin Ding, Chuxuan Liu, Xin Jin, Luyu Li, Hongyu Zhang, Mingwei Zhong, Yugang Cheng, et al.


  • Nanozymes induced Z-scheme Mn-BiVO4/Au/Bi2S3 heterostructure photoelectrochemical signal amplification for CA72-4 detection

    by Shi Peng, Junyi Fang, Zhaocheng Wu, Qian Xu, Huanxin Ding, Guangyong Zhang, Jin Jiao, Jiankang Zhu, Faying Li


  • Open Access

    Application of a novel anvil holder clamp in laparoscopic gastrectomy

    by Yuhai Qi, Linchuan Li, Bo Li, Sanyuan Hu, Jiankang Zhu, Guangyong Zhang

    Background: The reverse puncture method is a common reconstruction technique used in radical gastrectomy for gastric cancer. However, its widespread use is limited due to unstable clamping and unstable force directions, which complicate the anastomosis process. Therefore, we aimed to develop an improved clamp and investigated its application during the anastomotic process.Methods: This retrospective study included 29 patients who underwent laparoscopic-assisted Roux-en-Y total gastrectomy (n=16) or laparoscopic-assisted gastric tube proximal gastrectomy (n=13), utilizing reverse puncture circular anastomosis techniques during surgery. Intraoperatively, the anterior wall of the esophagus was opened using an anvil holder clamp to position the anvil, and a circular stapler was used to transect the esophagus. Finally, circular anastomosis was completed with assistance from our anvil holder clamp. We assessed the number of clamping attempts, time at each stage, clinical characteristics, and surgical outcomes.Results: All patients underwent successful laparoscopic radical gastrectomy. The mean number of attempts in the two stages was 1.14 and 1.03. The mean duration for these two procedures was 22.6 s and 27.9 s. The overall incidence of postoperative complications (Clavien–Dindo classification grade ≥II) was 17.2%. Esophagojejunostomy leakage occurred in one case (3.4%). Patients with anastomotic leakage were successfully managed with conservative treatment, with no cases of mortality.Conclusion: Our improved clamp is simple, safe, and effective for the anastomotic laparoscopic gastrectomy procedure and may benefit its wide application.


  • Open Access

    Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

    by Shufu Hou, Dandan Song, Ruiqi Hao, Linchuan Li, Yun Zhang, Jiankang Zhu

    Background: The Prognostic Nutritional Index (PNI) has become an important predictive tool for assessing patients’ nutritional status and immune competence. It is widely used in prognostic evaluations for various cancer patients. However, the prognostic relevance of the Prognostic Nutritional Index (PNI) in gastric or gastro-esophageal junction cancer patients (GC/GEJC) undergoing immune checkpoint inhibitors (ICIs) treatment remains unclear. This meta-analysis aimed to determine the prognostic impact of PNI in this specific patient cohort.Methods: We conducted a thorough literature search, covering prominent databases such as PubMed, Embase, Web of Science, SpringerLink, and the Cochrane Library. The search spanned from the inception of these databases up to December 5, 2023. Employing the 95% confidence interval and Hazard Ratio (HR), the study systematically evaluated the relationship between PNI and key prognostic indicators, including the objective remission rate (ORR), disease control rate (DCR), overall survival (OS) and progression-free survival (PFS) in GC/GEJC patients undergoing ICI treatment.Results: Eight studies comprising 813 eligible patients were selected. With 7 studies consistently demonstrating superior Overall Survival (OS) in the high-Prognostic Nutritional Index (PNI) group compared to their low-PNI counterparts (HR 0.58, 95% CI: 0.47–0.71, P<0.001). Furthermore, the results derived from 6 studies pointed out that the significant correlation between he low-PNI and poorer progression-free survival (PFS) (HR 0.58, 95% CI: 0.47–0.71, P<0.001). Subgroup analyses were performed to validate the robustness of the results. In addition, we conducted a meta-analysis of three studies examining the correlation between PNI and objective response rate/disease control rate (ORR/DCR) and found that the ORR/DCR was significantly superior in the high PNI group (ORR: RR: 1.24, P=0.002; DCR: RR: 1.43, P=0.008).Conclusion: This meta-analysis indicates that the low-PNI in GC/GEJC patients undergoing ICI treatment is significantly linked to worse OS and PFS. Therefore, PNI can serve as a prognostic indicator of post-treatment outcomes in patients with GC receiving ICIs. Further prospective studies are required to assess the reliability of these findings.Systematic review registration: https://inplasy.com/, identifier INPLASY202450133.


  • Open Access

    Prognostic relevance of platelet lymphocyte ratio (PLR) in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

    by Shufu Hou, Dandan Song, Yelei Zang, Ruiqi Hao, Linchuan Li, Jiankang Zhu

    Objectives: The prognostic relevance of the platelet-to-lymphocyte ratio (PLR) in gastric cancer (GC) patients undergoing immune checkpoint inhibitor (ICI) treatment remains unclear. This meta-analysis aimed to determine the prognostic impact of PLR in this specific patient cohort.Methods: We searched the PubMed, Cochrane Library, CNKI, and EMBASE databases, including literature published up to September 2023, to investigate the prognostic implications of PLR in patients with gastric cancer undergoing immune checkpoint inhibitor therapy. Outcome measures encompassed overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and disease control rates (DCR).Results: Nine studies from seven articles comprising 948 eligible patients were selected. The results revealed a significant correlation between elevated PLR and poorer OS and progression-free survival (PFS) (OS: HR 1.67, 95% CI 1.39–2.00, p < 0.001; PFS: HR 1.51, 95% CI 1.29–1.76, p < 0.001). Subgroup analyses were performed to validate the robustness of the results. Moreover, a meta-analysis of four studies investigating the correlation between the PLR in gastric cancer (GC) patients and the objective response rate/disease control rate (ORR/DCR), showed no significant association between the PLR and ORR/DCR (ORR: RR = 1.01, p = 0.960; DCR: RR = 0.96, p = 0.319).Conclusions: This meta-analysis indicates that elevated PLR in GC patients undergoing ICI treatment is significantly linked to worse OS and PFS. Therefore, PLR can serve as a prognostic indicator of post-treatment outcomes in patients with GC receiving ICIs. Further prospective studies are required to assess the reliability of these findings.Systematic review registration: https://inplasy.com/, identifier INPLASY2023120103.


  • Sleeve Gastrectomy Ameliorates Diabetes-Related Spleen Damage by Improving Oxidative Stress Status in Diabetic Obese Rats

    by Minggang Wang, Yacheng Xiong, Wei Zhu, Rexiati Ruze, Qian Xu, Zhibo Yan, Jiankang Zhu, Mingwei Zhong, Yugang Cheng, Sanyuan Hu, et al.

    Purpose Oxidative stress and inflammation are important pathogenic mediators in diabetes-related organ damage. Accumulating evidence suggests that immunodeficiency in diabetes is associated with diabetes-induced spleen damage. Sleeve gastrectomy (SG) has been proved to improve diabetes and its multiple associated complications. However, the ameliorative role of SG against spleen damage in diabetes has not been investigated. Materials and Methods Animal model of diabetic obese rats induced by high-fat diet (HFD) combined with streptozotocin (STZ) was treated with sham operation, caloric restriction, and SG. Metabolic parameters were measured, and the morphological and histopathological changes, status of oxidative stress, and levels of inflammatory factors were evaluated. Results SG reduced body weight and improved glucose tolerance and insulin sensitivity in diabetic obese rats. SG significantly reversed splenic atrophy and alleviated abnormalities of white and red pulp. Additionally, SG also reversed the increased splenocyte apoptosis (P < 0.001). Meanwhile, indicators of oxidative stress including reactive oxygen species (ROS), nitric oxide (NO), malondialdehyde (MDA), and protein carbonylation were reduced, and the activity and expression of antioxidant enzymes including SOD and CAT were improved after SG. The mRNA expression of inflammatory factors in SG groups such as TNF-α (P < 0.001), IL-6 (P < 0.001), MCP-1 (P < 0.01), and ICAM-1 (P < 0.001) was also significantly reduced. Conclusion SG ameliorates diabetes-related splenic injury by restoring the balance between oxidative stress process and antioxidant defense systems as well as reducing inflammation in the spleen. These findings indicate that SG is an appropriate therapeutic strategy for diabetes-related spleen damage.


  • PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways

    by A. L. Feng, X. Han, X. Meng, Z. Chen, Q. Li, W. Shu, H. Dai, J. Zhu, Z. Yang

    Purpose To investigate the role of PRDX2 in esophageal carcinoma (ESCA). Methods The expression of PRDX2 was detected in ESCA tissues. And PRDX2 expression in two ESCA cell lines was knocked down. Cell proliferation, metastasis and invasion were detected in these cells. Results Here, we found that PRDX2 expression was significantly increased in ESCA tissues and was associated with a poor prognosis in ESCA patients. In addition, PRDX2 expression was significantly associated with pathological grading, infiltration degree and 5-year survival time in ESCA patients. Next, we knocked down PRDX2 expression by PRDX2-shRNA transfection in two ESCA cell lines, Eca-109 and TE-1. Proliferation analysis indicated that in vitro PRDX2 knockdown decreased growth and clone formation of ESCA cells. Scratch and transwell assays indicated that cell migration and invasion were significantly inhibited by PRDX2 knockdown. In addition, PRDX2 knockdown inhibited cell cycle of ESCA cells and down-regulated Cyclin D1-CDK4/6. Moreover, PRDX2 knockdown regulated proteins involved in mitochondrial-dependent apoptosis, including increased Bax and Caspase9/3 and decreased Bcl2. Mechanism investigation indicated that PRDX2 knockdown led to inactivation of Wnt/β-catenin and AKT pathways. Conclusions Our data suggest that PRDX2 may function as an oncogene in the development of ESCA via regulating Wnt/β-catenin and AKT pathways. Our study fills a gap in the understanding of the role of PRDX2 in ESCA and provides a potential target for ESCA treatment.


  • Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC

    by A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu

    To gain a clear picture of the influence of postoperative adjuvant transcatheter arterial chemoembolization (TACE) on recurrence after curative resection for HCC.According to the inclusion criteria...